CI Global Health Sciences Corporate Class

Series A USD
As of July 21, 2023 CI Global Health Sciences Corporate Class Z (ISC 2926) (DSC 2927) (LL 2929) merged into (ISC 301) (DSC 401) (LL 1401)
 

Fund overview

This fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Fund details

description of elementelement value
Inception date July 1996
CAD Total net assets ($CAD)
As at 2024-04-30
$155.8 million
NAVPS
As at 2024-05-24
$40.7050
MER (%)
As at 2023-09-30
2.34
Management fee (%) 1.90
Asset class Sector Equity
Currency USD
Minimum investment $500 initial/$25 additional
Distribution frequency Quarterly
Last distribution $0.7240

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

A ISC 301
DSC SO* 401
LL SO 1401
F 324
P 90324
*No new purchases directly into switch only funds.

Performance2 As at 2024-04-30

Growth of $10,000 (Since inception date)

growth of 10k graph

Calendar year performance

annual performance graph

average annual compound returns

YTD 1 Mo 3 Mo 6 Mo 1 Y 3 Y 5 Y 10 Y Inception*
2.46% -4.13% 1.40% 10.90% 4.90% -2.47% 4.10% 1.69% 7.83%
*Since inception date

Distribution history3

Payable date Total
2022-03-25 0.7240
2021-03-26 0.2492
2020-12-18 0.3973
2020-09-25 0.3778
2020-06-26 0.2765
Payable date Total
2020-03-20 0.6464
2019-12-13 0.4049
2019-09-27 0.4529
2019-06-21 0.4275
2019-03-22 0.6736

Management team

First we'll display the Team Company and then the Team members
Greg Quickmire
Peter Hofstra

CI Global Health Sciences Corporate Class

Series A USD
As of July 21, 2023 CI Global Health Sciences Corporate Class Z (ISC 2926) (DSC 2927) (LL 2929) merged into (ISC 301) (DSC 401) (LL 1401)
 
Portfolio allocations4 As at 2024-04-30
Asset allocation (%)
  • US Equity 76.24
  • International Equity 21.60
  • Cash and Equivalents 2.16
Sector allocation (%)
  • Healthcare 94.36
  • Exchange Traded Fund 2.49
  • Cash and Cash Equivalent 2.16
  • Consumer Services 0.99
Geographic allocation(%)
  • United States 78.28
  • United Kingdom 9.57
  • Denmark 7.60
  • Germany 3.03
  • Switzerland 1.45
  • Canada 0.07
Top holdings
Sector (%)
1. Eli Lilly and Co Drugs 10.37%
2. UnitedHealth Group Inc Healthcare Services 9.45%
3. Novo Nordisk A/S Cl B Drugs 7.60%
4. Merck & Co Inc Drugs 6.62%
5. AstraZeneca PLC Drugs 6.35%
6. Thermo Fisher Scientific Inc Healthcare Equipment 4.97%
7. Anthem Inc Healthcare Services 4.87%
8. AbbVie Inc Drugs 4.26%
9. Zoetis Inc Cl A Drugs 4.25%
10. Cigna Corp Healthcare Services 4.06%
11. Usd Cash Sweep Cash and Cash Equivalent 3.30%
12. Gsk Plc Drugs 3.20%
13. Boston Scientific Corp Healthcare Equipment 3.12%
14. Siemens Healthineers AG Healthcare Equipment 3.03%
15. Stryker Corp Healthcare Equipment 3.02%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.